EchoStar stock becomes SpaceX IPO proxy after 60K options

EchoStar’s options tape is no longer a sideshow to the SpaceX IPO. It is the first public stress test of the frenzy, with traders using the satellite company as a liquid proxy before they can buy the rocket maker itself.

More than 60,000 EchoStar options contracts changed hands on Wednesday, more than three times the daily average, with total premium just shy of $50 million, according to CNBC’s report on the trading surge. Plain attraction: EchoStar owns an estimated 3 per cent of SpaceX, while SpaceX is targeting a fixed $135 IPO price that would value Elon Musk’s company at about $1.77 trillion.

For traders shut out of the private-market allocation, that stake gives EchoStar a job it was not built to do. Few listed instruments let public-market accounts express the view at all. Scarce shares, a crowded demand signal and adjacent vehicles now matter as much as the underlying question of what SpaceX is worth.

Why EchoStar caught the flow

Arithmetic explains the first wave of buying. At a $1.77 trillion SpaceX valuation, EchoStar’s 3 per cent stake would be worth about $53.1 billion before taxes, discounts, debt, liquidity limits or any holding-company haircut. Set beside a reported EchoStar market value around $35 billion, the look-through math gives traders a simple long case before they have to underwrite every line of the networking business.

No tracking-stock mechanics sit underneath that math. EchoStar does not hold a floating claim on SpaceX that reprices tick-for-tick, and it still carries its own operating assets, capital structure and telecom-sector risk. In options terms, the burst looks less like a neat hedge than a way to buy convexity around an event whose direct float is constrained.

Daniel Ives, in a Bloomberg interview on the IPO, framed the deal as a bet on Musk as much as on any single set of launch or satellite-internet numbers. His framing helps explain why EchoStar can catch flows even when the exact look-through value is hard to pin down.

Renos Savvides of Neuberger put the psychology more bluntly in The New York Times’ account of Wall Street’s SpaceX chase:

“More people are biased to participate than not because no one wants to miss it”

Renos Savvides, Neuberger

Such fear of missing out matters because SpaceX is not arriving as a normal offering. The company is landing as the largest possible equity story in a market already trained to bid anything with scarcity, founder control and a route into artificial intelligence, defense or space infrastructure. With a listed ticker and a developed options chain, EchoStar gives that demand somewhere to go. For a rush, that may be enough. For durable valuation support, it is a thinner argument.

Access is the trade

The proxy scramble extends beyond EchoStar. Space-themed ETFs, directed-share allocations and pre-IPO derivatives have all become part of the access market, each with a different flaw. CNBC said the NASA ETF had drawn $2.6 billion over two months as investors sought SpaceX exposure through exchange-traded funds. MarketWatch reported that SpaceX plans to reserve 5 per cent of IPO shares for staff, friends and family, tightening the pool available to ordinary buyers.

Crypto markets have already shown the danger in that demand. Ventuals said it would compensate users after a pre-IPO SpaceX perpetual contract on Hyperliquid plunged 45 per cent within minutes. Reference prices were thin, disclosures were changing and the crowd was leaning the same way.

Against that backdrop, EchoStar looks cleaner than a pre-IPO perpetual because it is an actual listed equity with a reported ownership stake. Post-IPO SpaceX shares would still be a cleaner instrument, but those shares are not yet available. As access gets more rationed, traders may place more value on any instrument pointing in the right direction, even when the tracking error is large.

The valuation gap

Skeptics start with price. Morningstar analysts, cited by CNBC, described SpaceX’s IPO target as “significantly overvalued” and estimated the company was worth less than half of the $1.75 trillion valuation being discussed.

“significantly overvalued”

Morningstar analysts, via CNBC

Two failure modes follow from that lower fair-value estimate. SpaceX could trade down after the listing, pulling the look-through stake lower. Alternatively, SpaceX could trade well enough while EchoStar holders still face a discount because they own the exposure indirectly, with no promise that the market will capitalise the stake at face value.

Disclosure risk sits alongside valuation. CNBC reported that skeptics were focused on comments from Musk that appeared to diverge from IPO filing language around a large Anthropic compute arrangement. Musk described that arrangement as a shorter commitment than some investors first assumed, saying in a post quoted by MarketWatch: “This is a 180-day lease with 90-day notice mutual cancellation thereafter.”

TechCrunch separately noted that SpaceX warned it may issue “significant” equity in future transactions. Direct IPO buyers have to treat that as a dilution and governance question. EchoStar traders face a second-order problem: the proxy is only as useful as the market’s confidence in the asset it is supposed to represent.

Options traders can live with uncertainty when the catalyst is large enough. Crowded squeezes are less forgiving. A holder who wants long-term SpaceX exposure may tolerate the gap between proxy and asset. A trader buying weekly calls on EchoStar may not get the time to be philosophical.

What changes after pricing

Pricing day will test whether SpaceX’s first trades validate the proxy chain or break it. With a strong debut and limited float, demand could stay pinned to side vehicles, especially if institutions cannot build the positions they want on day one. MarketWatch has already argued that buying into mega-IPOs such as SpaceX and Anthropic could create index-fund complications as passive products absorb companies with unusually large valuations and unusual ownership profiles.

Poor trading would force a different sort of discipline. Investors would have to separate SpaceX’s strategic story from the access trade, and EchoStar would have to trade more on the discounted value of its stake and less on the hope that every scarce Musk-linked asset deserves a premium.

EchoStar, then, is useful as a market tell. The stock reflects more than enthusiasm for rockets or Starlink. A record IPO is already distorting the instruments around it before the issuer has printed a single public-market trade. Ordinarily, SpaceX’s valuation debate would happen in SpaceX shares. For now, it is happening in EchoStar options, ETFs and synthetic contracts, where scarcity can be as powerful as fundamentals and much harder to model.

SpaceX has made imperfect shadows of itself valuable enough for public investors to chase. The IPO has not opened yet, but the squeeze around access already has.